SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001682852-23-000004
Filing Date
2023-01-09
Accepted
2023-01-09 07:03:40
Documents
13
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrna-20230109.htm   iXBRL 8-K 39765
2 EX-99.1 exhibit991-jpmjan2023.htm EX-99.1 39238
  Complete submission text file 0001682852-23-000004.txt   225679

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20230109.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20230109_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20230109_pre.xml EX-101.PRE 12510
7 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20230109_htm.xml XML 11354
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 23516516
SIC: 2836 Biological Products, (No Diagnostic Substances)